Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Long Term Debt

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) (AMHCU) currently reports a long-term debt of $0 as of June 2026. That compares with $200K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s long-term debt history and peer comparisons.

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s long-term debt decreased from $200K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) reported $0 in long-term debt as of June 2026. That compares with $200K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jasper Therapeutics- Units (1 Ord Class A & 1/2 War), and consider following AMHCU for alerts when major investors trade the stock.